Tygacil Lyophilisate For Solution For Injection 50Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • Weekly Ad

Tygacil: Lyophilisate for solution for injection (50mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

TIGECYCLINE is a glycylcycline antibiotic. It is used to treat certain kinds of bacterial infections. It will not work for colds, the flu, or other viral infections.

In-Depth Information
Select a Medication

Tygacil 50mg Powder for Injection

NDC: 000084990
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Intraabdominal Infections, Skin And Skin Structure Infections, Community-acquired Pneumonia

Storage Information
Store unreconstituted product at 68 to 77 degrees F; excursions permitted to 59 to 86 degrees F
Reconstituted product may be refrigerated (36 to 46 degrees F) for use within 45 hours
Reconstituted product may be stored at controlled room temperature (68 to 77 degrees F) for use within 6 hours
Tygacil 50mg Powder for Injection

Reported Side Effects for Tygacil 50mg Powder for Injection

Vaginal Infection Incidence:
<2.0%*
Severity: MODERATE
Onset: DELAYED
Infection Incidence:
<7.0%*
Severity: MILD
Onset: DELAYED
Yellow Skin Incidence:
<2.0%*
Severity: MODERATE
Onset: DELAYED
Chills Incidence:
<2.0%*
Severity: MILD
Onset: RAPID
Metallic Taste Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Eosinophilia Incidence:
<2.0%*
Severity: MODERATE
Onset: DELAYED
Injection Site Reaction Incidence:
<2.0%*
Severity: MILD
Onset: RAPID
Vaginal Discharge Incidence:
<2.0%*
Severity: MILD
Onset: DELAYED
Prolonged Bleeding Time Incidence:
<2.0%*
Severity: MODERATE
Onset: DELAYED
Swelling Incidence:
<2.0%*
Severity: MODERATE
Onset: DELAYED
Low Calcium Levels Incidence:
<2.0%*
Severity: MODERATE
Onset: DELAYED
Low Blood Sugar Incidence:
<2.0%*
Severity: MODERATE
Onset: EARLY
Yeast Infection Incidence:
<2.0%*
Severity: MODERATE
Onset: DELAYED
Decreased Appetite Incidence:
<2.0%*
Severity: MILD
Onset: DELAYED
Itching Incidence:
<2.0%*
Severity: MILD
Onset: RAPID
Low Platelet Count Incidence:
<2.0%*
Severity: MODERATE
Onset: DELAYED
Low Blood Sodium Levels Incidence:
2.0%*
Severity: MODERATE
Onset: DELAYED
Upset Stomach Incidence:
2.0%*
Severity: MILD
Onset: EARLY
High Bilirubin Level Incidence:
2.0%*
Severity: MODERATE
Onset: DELAYED
Skin Rash Incidence:
3.0%*
Severity: MILD
Onset: EARLY
Irritated Blood Vessels Incidence:
3.0%*
Severity: MODERATE
Onset: RAPID
Decreased Healing Incidence:
3.0%*
Severity: MODERATE
Onset: DELAYED
High Amylase Levels Incidence:
3.0%*
Severity: MODERATE
Onset: DELAYED
Elevated Hepatic Enzymes Incidence:
3.0-5.0%*
Severity: MODERATE
Onset: DELAYED
Lightheadedness Incidence:
3.0%*
Severity: MILD
Onset: EARLY
Low Kidney Function Incidence:
3.0%*
Severity: SEVERE
Onset: DELAYED
Weakness Incidence:
3.0%*
Severity: MILD
Onset: DELAYED
Anemia Incidence:
5.0%*
Severity: MODERATE
Onset: DELAYED
Headache Incidence:
6.0%*
Severity: MILD
Onset: EARLY
Stomach Pain Incidence:
6.0%*
Severity: MILD
Onset: EARLY
Loose Stools Incidence:
12.0%*
Severity: MILD
Onset: EARLY
Vomiting Incidence:
18.0%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
26.0%*
Severity: MILD
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

SECOND Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

THIRD Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Tygacil

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5